Obinutuzumab (Gazyva)

Indications

  • xxx

Pharmacology

  • Glycoengineered Type II Monoclonal Antibody Against B-Cell CD20 (see Anti-CD20 Therapy, [[Anti-CD20 Therapy]])

Metabolism

  • xxx

Administration

  • xxx

Dose Adjustment

  • Hepatic: xxx
  • Renal: xxx

Adverse Effects

Other Adverse Effects

  • xxx
  • xxx
  • xxx
  • xxx

References

  • xxx